1 |
Vetrivel, K. S. & Thinakaran, G. Amyloidogenic processing of -amyloid precursor protein in intracellular compartments. Neurology 66:S69-S73 (2006)
DOI
ScienceOn
|
2 |
Pereira, C. et al. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies. Curr Drug Targets CNS Neurol Disord 4:383-403 (2005).
DOI
|
3 |
Lorenzo, A. & Yankner, B. A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci U S A 91:12243-12247 (1994)
|
4 |
Allsop, D., Howlett, D., Christie, G. & Karran, E. Fibrillogenesis of beta-amyloid, Biochem Soc Trans 26: 459-463 (1998)
DOI
|
5 |
Ono, K., Hasegawa, K., Naiki, H. & Yamada, M. Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro, Biochem Biophys Res Commun 330:111-116 (2005)
DOI
ScienceOn
|
6 |
Pallitto, M. M. et al. Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity. Biochemistry 38:3570-3578 (1999)
DOI
ScienceOn
|
7 |
Hofmeister, F. Zur Lehre von der Wirkung der Salze. [Title translation: About the science of the effect of salts.] Arch Exp Pathol Pharmakol 24:247-260 (1888)
DOI
|
8 |
Wang, S. S., Chen, Y. T. & Chou, S. W. Inhibition of amyloid fibril formation of beta-amyloid peptides via the amphiphilic surfactants. Biochim Biophys Acta 1741:307-313 (2005)
DOI
|
9 |
Riviere, C. et al. Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro. Bioorg Med Chem 15:1160-1167 (2007)
DOI
ScienceOn
|
10 |
Soto, C., Castano, E. M., Frangione, B. & Inestrosa, N. C. The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation. J Biol Chem 270:3063-3067 (1995)
DOI
ScienceOn
|
11 |
Subramaniam, R. et al. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide (25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease, Neurochem Res 23:1403-1410 (1998)
DOI
ScienceOn
|
12 |
Merlini, G. et al. Interaction of the anthracycline 4'- iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci U S A 92:2959-2963 (1995)
|
13 |
Sallam, K. I. Antimicrobial and antioxidant effects of sodium acetate, sodium lactate, and sodium citrate in refrigerated sliced salmon. Food Control 18:566-575 (2007)
DOI
ScienceOn
|
14 |
Selkoe, D. J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399:A23-A31 (1999)
DOI
ScienceOn
|
15 |
Seiffert, D. et al. Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. J Biol Chem 275:34086-34091 (2000)
DOI
ScienceOn
|
16 |
Pike, C. J. et al. Neurodegeneration induced by betaamyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676-1687 (1993)
DOI
|
17 |
Scarpini, E., Scheltens, P. & Feldman, H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol 2:539-547 (2003)
DOI
ScienceOn
|
18 |
McConnell, S. & Riggs, J. Alzheimer's research: can it help save our nation's entitlement programs? Alzheimer Dementia 1:84-86 (2005)
DOI
ScienceOn
|
19 |
Lomakin, A. et al. On the nucleation and growth of amyloid beta-protein fibrils: Detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci U S A 93:1125-1129 (1996)
|
20 |
Ghanta, J., Shen, C. L., Kiessling, L. L. & Murphy, R. M. A strategy for designing inhibitors of beta-amyloid toxicity. J Biol Chem 271:29525-29528 (1996)
DOI
ScienceOn
|
21 |
Citron, M. Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci 5:677-685 (2004)
DOI
ScienceOn
|
22 |
Soto, C. et al. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy. Nat Med 4:822-826 (1998)
DOI
ScienceOn
|
23 |
McWilliam Leitch, E. C. & Stewart, C. S. Susceptibility of Escherichia coli O157 and non-O157 isolates to lactate. Lett Appl Microbiol 35:176-180 (2002)
DOI
ScienceOn
|
24 |
Kihara, T. et al. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity, Ann Neurol 42:159-163 (1997)
DOI
ScienceOn
|
25 |
Cummings, J. L., Doody, R. & Clark, C. Disease-modifying therapies for Alzheimer disease: Challenges to early intervention. Neurology 69:1622-1634 (2007)
DOI
ScienceOn
|
26 |
Barrow, C. J., Yasuda, A., Kenny, P. T. & Zagorski, M. G. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra, J Mol Biol 225:1075-1093 (1992)
DOI
|
27 |
Sisodia, S. S. & St George-Hyslop, P. H. Gamma- Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat Rev Neurosci 3:281-290 (2002)
DOI
ScienceOn
|
28 |
Mook-Jung, I. et al. Estrogen blocks neurotoxic effects of beta-amyloid (1-42) and induces neurite extension in B103 cells. Neurosci Lett 235:101-104 (1997)
DOI
ScienceOn
|
29 |
Soto, C., Kindy, M. S., Baumann, M. & Frangione, B. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun 226:672-680 (1996)
DOI
ScienceOn
|
30 |
Goodman, Y., Steiner, M. R., Steiner, S. M. & Mattson, M. P. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation, Brain Res 654:171-176 (1994)
DOI
ScienceOn
|
31 |
Pike, C. J. et al. Structure-activity analyses of betaamyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 64:253-265 (1995)
DOI
ScienceOn
|
32 |
Porat, Y., Abramowitz, A. & Gazit, E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67:27-37 (2006)
DOI
ScienceOn
|
33 |
Findeis, M. A. et al. Modified-peptide inhibitors of amyloid beta-peptide polymerization. Biochemistry 38:6791-6800 (1999)
DOI
ScienceOn
|
34 |
Ishiyama, M. et al. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 19:1518-1520 (1996)
DOI
ScienceOn
|
35 |
Yankner, B. A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16:921-932 (1996)
DOI
ScienceOn
|
36 |
Pike, C. J., Walencewicz, A. J., Glabe, C. G. & Cotman, C. W. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563:311-314 (1991)
DOI
ScienceOn
|
37 |
Kisilevsky, R. et al. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat Med 1:143-148 (1995)
DOI
|
38 |
Wood, S. J. et al. Selective inhibition of Abeta fibril formation. J Biol Chem 271:4086-4092 (1996)
DOI
|
39 |
Ono, K. et al. Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro. Exp Neurol 189:380-392 (2004)
DOI
ScienceOn
|
40 |
Marcinowski, K. J., Shao, H., Clancy, E. L. & Zagorski, M. G. Solution structure model of residues 1-28 of the amyloid beta peptide when bound to micelles. J Am Chem Soc 120:11082-11091 (1998)
DOI
ScienceOn
|
41 |
Hilbich, C. et al. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. J Mol Biol 228:460-473 (1992)
DOI
|
42 |
Zhang, Y. & Cremer, P. S. Interactions between macromolecules and ions: The Hofmeister series. Curr Opin Chem Biol 10:658-663 (2006)
DOI
ScienceOn
|
43 |
Pappolla, M. et al. Inhibition Alzheimer beta-fibrillogenesis by melatonin. J Biol Che 273: 7185-7188 (1998)
DOI
ScienceOn
|
44 |
Puntel, R. L. et al. Antioxidant properties of Krebs cycle intermediates against malonate pro-oxidant activity in vitro: a comparative study using the colorimetric method and HPLC analysis to determine malondialdehyde in rat brain homogenates. Life Sci 81:51-62 (2007)
DOI
ScienceOn
|
45 |
Yonekawa, C., Nakae, H., Tajimi, K. & Asanuma, Y. Effectiveness of combining plasma exchange and continuous hemodiafiltration in patients with postoperative liver failure. Artificial Organs 29:324-328 (2005)
DOI
ScienceOn
|
46 |
Selkoe, D. J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766 (2001)
DOI
|
47 |
Lin, S. J., Shiao, Y. J., Chi, C. W. & Yang, L. M. Abeta aggregation inhibitors: Part 1. Synthesis and biological activity of phenylazo benzenesulfonamides. Bioorg Med Chem Lett 14:1173-1176 (2004)
DOI
ScienceOn
|
48 |
Soto, C. & Castano, E. M. The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis. Biochem J 314:701-707 (1996)
DOI
|
49 |
Findeis, M. A. et al. Characterization of cholyl-leuval- phe-phe-ala-OH as an inhibitor of amyloid betapeptide polymerization. Amyloid 8:231-241 (2001)
DOI
ScienceOn
|
50 |
Salomon, A. R., Marcinowski, K. J., Friedland, R. W. & Zagorski, M. G. Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry 35:13568-13578 (1996)
DOI
ScienceOn
|